JO3769B1 - RNAi Therapy for Hepatitis B Virus Infection - Google Patents
RNAi Therapy for Hepatitis B Virus InfectionInfo
- Publication number
- JO3769B1 JO3769B1 JOP/2016/0170A JOP20160170A JO3769B1 JO 3769 B1 JO3769 B1 JO 3769B1 JO P20160170 A JOP20160170 A JO P20160170A JO 3769 B1 JO3769 B1 JO 3769B1
- Authority
- JO
- Jordan
- Prior art keywords
- hepatitis
- virus infection
- triggers
- rnai
- hbv
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
<strong>Described are compositions and methods for inhibition of Hepatitis B virus gene expression. RNA interference (RN Ai) triggers and RNAi trigger conjugates for inhibiting the expression of Hepatitis B virus gene are described. Pharmaceutical compositions comprising one or more HBV RNAi triggers optionally with one or more additional therapeutics are also described. Delivery of the described HBV RNAi triggers to infected liver in vivo provides for inhibition of HBV gene expression and treatment.</strong>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562202253P | 2015-08-07 | 2015-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3769B1 true JO3769B1 (en) | 2021-01-31 |
Family
ID=59687542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2016/0170A JO3769B1 (en) | 2015-08-07 | 2016-08-04 | RNAi Therapy for Hepatitis B Virus Infection |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR105611A1 (en) |
JO (1) | JO3769B1 (en) |
TW (2) | TWI794884B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8501930B2 (en) * | 2010-12-17 | 2013-08-06 | Arrowhead Madison Inc. | Peptide-based in vivo siRNA delivery system |
JP6165723B2 (en) * | 2011-06-30 | 2017-07-19 | アローヘッド ファーマシューティカルズ インコーポレイテッド | Compositions and methods for inhibiting gene expression of hepatitis B virus |
-
2016
- 2016-08-04 JO JOP/2016/0170A patent/JO3769B1/en active
- 2016-08-05 TW TW110125844A patent/TWI794884B/en active
- 2016-08-05 TW TW105125092A patent/TWI761308B/en active
- 2016-08-05 AR ARP160102399A patent/AR105611A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201717971A (en) | 2017-06-01 |
TWI794884B (en) | 2023-03-01 |
TW202142242A (en) | 2021-11-16 |
AR105611A1 (en) | 2017-10-18 |
TWI761308B (en) | 2022-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20170161A1 (en) | RNAi Agents for Hepatitis B Virus Infection | |
WO2017027350A3 (en) | Rnai therapy for hepatitis b virus infection | |
ZA202106265B (en) | Compositions and methods for inhibiting gene expression of lpa | |
PH12017500614A1 (en) | Compositions and methods for silencing hepatitis b virus gene expression | |
MX2022011756A (en) | Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor. | |
MX2021006635A (en) | Hepatitis b virus (hbv) irna compositions and methods of use thereof. | |
MX2018005230A (en) | Combination therapy of an hbv capsid assembly inhibitor and an interferon. | |
MX2022009352A (en) | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus. | |
JOP20210208A1 (en) | Rnai agents for hepatitis b virus infection | |
MX371093B (en) | Microrna compounds and methods for modulating mir-122. | |
MX2017014641A (en) | Compositions and methods for inhibiting gene expression of hif2alpha. | |
MX354676B (en) | Benzofuran compounds for the treatment of hepatitis c virus infections. | |
JO3769B1 (en) | RNAi Therapy for Hepatitis B Virus Infection | |
PH12018502320A1 (en) | Reagents for treatment of hepatitis b virus (hbv) infection and use thereof | |
EA201990427A1 (en) | RNAi AGENTS AGAINST INFECTION CAUSED BY HEPATITIS B VIRUS |